Letícia Rangel

Federal University of Espirito Santo

Leticia B. A. Rangel, Pharm.D., Ph.D., is a Full Professor of the Department of Pharmaceutical Sciences, as well as a member of the Biotechnology Program/RENORBIO and the Biochemistry and Pharmacology Program at the Federal University of Espirito Santo (UFES). As the Head of the Laboratory of Cellular and Molecular Biology of Human Cancer, she coordinates projects on ovarian and breast cancers, with emphasis on the cellular and molecular mechanisms of these diseases, the development of biotechnology products and processes, and the discovery of new anticancer molecules. Her scientific network includes the Institute of Biophysics Carlos Chagas Filho (Federal University of Rio de Janeiro), the Division of Clinical Research of the Brazilian National Cancer Institute, The Department of Molecular Medicine, University of Texas at San Antonio (USA), the H. Lee Moffitt Cancer Center (USA), and the Department of Pathology at the John Hopkins University (USA), as well as the private sector. Aside from papers published in international journals, and ongoing patent negotiations, she has been awarded by the Brazilian government in recognition to her contribution in cancer research.

3books edited

5chapters authored

Latest work with IntechOpen by Letícia Rangel

This edited volume, Hormone Therapy and Replacement in Cancer and Aging-related Diseases, is a collection of reviewed and relevant research chapters, offering a comprehensive overview of recent developments in the field of hormone replacement therapy. The book comprises single chapters authored by various researchers and edited by experts active in the hormone replacement therapy research area. All chapters are complete in themselves but united under a common research study topic. This publication aims at providing a thorough overview of the latest research efforts by international authors on hormone replacement therapy, and opens new possible research paths for further novel developments.

Go to the book